Chatham Capital Group, Inc. Danaher Corp Transaction History

Chatham Capital Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 21, 2023	SELL	$239.75 - $277.0 $63,533 - $73,405	-265 Reduced 24.54%	815 $205,000
Q4 2022 Jan 31, 2023	SELL	$241.42 - $282.29 $60,355 - $70,572	-250 Reduced 18.8%	1,080 $286,000
Q2 2022 Aug 02, 2022	BUY	$237.11 - $299.66 $6,639 - $8,390	28 Added 2.15%	1,330 $337,000
Q2 2021 Jul 28, 2021	BUY	$225.08 - $271.69 $58,070 - $70,096	258 Added 24.71%	1,302 $349,000
Q1 2021 Apr 29, 2021	BUY	$212.38 - $245.9 $221,724 - $256,719	1,044 New	1,044 $235,000

2,432

563M

3.94M

4.11M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $177B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Chatham Capital Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Chatham Capital Group, Inc. with notifications on news.